Posted by ShawnThomas on February 24, 2008, at 23:44:05
In reply to A, posted by Markwell on February 24, 2008, at 17:10:58
I speculate that it could be on the market in two to four years. Phase III clinical trials are ongoing in the United States. See http://www.neurotransmitter.net/agomelatine.jpg for details about some of agomelatine's clinical trials; the table was created by Daniela Eser, Thomas C. Baghai, & Hans-Jürgen Möller in 2007 (http:///pubmed.gov/17917562). Check out http://pubmed.gov?cmd=Search&db=pubmed&term=agomelatine for more research about the drug.
Shawn
poster:ShawnThomas
thread:814485
URL: http://www.dr-bob.org/babble/neuro/20080204/msgs/814537.html